カレントテラピー　32-6　サンプル page 15/32

このページは カレントテラピー　32-6　サンプル の電子ブックに掲載されている15ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　32-6　サンプル

Current Therapy 2014 Vol.32 No.6 55気分障害研究のトピックス561参考文献1） Kupfer DJ：Long-term treatment of depression. J Clin Psychiatry52（ Suppl）：28-34, 19912） 三島和夫：精神疾患に合併する睡眠障害の診断・治療の実態把握と睡眠医療の適正化に関する研究．厚生労働科学研究費補助金・こころの健康科学研究事業「精神疾患に合併する睡眠障害の診断・治療の実態把握と睡眠医療の適正化に関する研究」平成20年度総括・分担研究報告書．5-27, 20093） Fava GA, Fabbri S, Sonino N：Residual symptoms in depression：an emerging therapeutic target. Prog NeuropsychopharmacolBiol Psychiatry 26：1019-1027, 20024） Menza M, Marin H, Opper RS：Residual symptoms indepression：can treatment be symptom-specific? J Clin Psychiatry64：516-523, 20035） McClintock SM, Husain MM, Wisniewski SR, et al：Residualsymptoms in depressed outpatients who respond by 50％ butdo not remit to antidepressant medication. J Clin Psychopharmacol31：180-186, 20116） Nierenberg AA, Keefe BR, Leslie VC, et al：Residual symptomsin depressed patients who respond acutely to fluoxetine.J Clin Psychiatry 60：221-225, 19997） Iwaki S, Satoh K, Matsumoto Y, et al：Treatment-ResistantResidual Insomnia in Patients with Recurrent Major DepressiveEpisodes. Sleep Biol Rhythm 10：202-211, 20128） NIH State of the Science Conference statement on Manifestationsand Management of Chronic Insomnia in Adults statement.J Clin Sleep Med 1：412-421, 20059） Manber R, Edinger JD, Gress JL, et al：Cognitive behavioraltherapy for insomnia enhances depression outcome inpatients with comorbid major depressive disorder and insomnia.Sleep 31：489-495, 200810） Watanabe N, Furukawa TA, Shimodera S, et al：Brief behavioraltherapy for refractory insomnia in residual depression：an assessor-blind, randomized controlled trial. J Clin Psychiatry72：1651-1658, 201111） Fava M, McCall WV, Krystal A, et al：Eszopiclone co -administered with fluoxetine in patients with insomnia coexistingwith major depressive disorder. Biol Psychiatry 59：1052-1060, 200612） Fava M, Schaefer K, Huang H, et al：A post hoc analysis ofthe effect of nightly administration of eszopiclone and aselective serotonin reuptake inhibitor in patients with insomniaand anxious depression. J Clin Psychiatry 72：473-479,201113） Ford DE, Kamerow DB：Epidemiologic study of sleep disturbancesand psychiatric disorders. An opportunity for prevention?JAMA 262：1479-1484, 198914） Coleman RM, Roffwarg HP, Kennedy SJ, et al：Sleep-wakedisorders based on a polysomnographic diagnosis. A nationalcooperative study. JAMA 247：997-1003, 198215） Baglioni C, Battagliese G, Feige B, et al：Insomnia as a predictorof depression：a meta-analytic evaluation of longitudinalepidemiological studies. J Affect Disord 135：10-19, 201116） Casper RC, Katz MM, Bowden CL, et al：The pattern ofphysical symptom changes in major depressive disorder followingtreatment with amitriptyline or imipramine. J AffectDisord 31：151-164, 199417） A?argun MY, Kara H, Solmaz M：Subjective sleep qualityand suicidality in patients with major depression. J PsychiatrRes 31：377-381, 199718） Perlis ML, Giles DE, Buysse DJ, et al：Self-reported sleepdisturbance as a prodromal symptom in recurrent depression.J Affect Disord 42：209-212, 199719） Ohayon MM, Roth T：Place of chronic insomnia in thecourse of depressive and anxiety disorders. J Psychiatr Res37：9-15, 200320） Tranter R, O’Donovan C, Chandarana P, et al：Prevalenceand outcome of partial remission in depression. J PsychiatryNeurosci 27：241-247, 200221） Paykel ES, Ramana R, Cooper Z, et al：Residual symptomsafter partial remission：an important outcome in depression.Psychol Med 25：1171-1180, 199522） Holsboer F, von Bardeleben U, Steiger A：Effects of intravenouscorticotropin -releasing hormone upon sleep -relatedgrowth hormone surge and sleep EEG in man. Neuroendocrinology48：32-38, 198823） Vgontzas AN, Bixler EO, Lin HM, et al：Chronic insomnia isassociated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis：clinical implications. J Clin EndocrinolMetab 86：3787-3794, 200124） Bauer M, Bschor T, Pfennig A, et al；WFSBP Task Force onUnipolar Depressive Disorders：World Federation of Societiesof Biological Psychiatry（WFSBP）Guidelines for BiologicalTreatment of Unipolar Depressive Disorders in PrimaryCare. World J Biol Psychiatry 8：67-104, 200725） Wilson S, Argyropoulos S：Antidepressants and sleep：aqualitative review of the literature. Drugs 65：927-947, 200526） Thase ME：Antidepressant treatment of the depressedpatient with insomnia. J Clin Psychiatry 60 （Suppl 17）：28-31, 199927） Markkula J, Lauerma H：Mianserin and restless legs. IntClin Psychopharmacol 12：53-58, 199728） Yang C, White DP, Winkelman JW：Antidepressants andperiodic leg movements of sleep. Biol Psychiatry 58：510-514, 200529） Schmid DA, Wichniak A, Uhr M, et al：Changes of sleeparchitecture, spectral composition of sleep EEG, the nocturnalsecretion of cortisol, ACTH, GH, prolactin, melatonin,ghrelin, and leptin, and the DEX -CRH test in depressedpatients during treatment with mirtazapine. Neuropsychopharmacology31：832-844, 200630） DeBattista C, Lembke A, Solvason HB, et al：A prospectivetrial of modafinil as an adjunctive treatment of major depression.J Clin Psychopharmacol 24：87-90, 200431） Menza MA, Kaufman KR, Castellanos A：Modafinil augmentationof antidepressant treatment in depression. J Clin Psychiatry61：378-381, 200032） Ninan PT, Hassman HA, Glass SJ, et al：Adjunctive modafinilat initiation of treatment with a selective serotonin reuptakeinhibitor enhances the degree and onset of therapeuticeffects in patients with major depressive disorder andfatigue. J Clin Psychiatry 65：414-420, 200433） Fava M, Thase ME, DeBattista C：A multicenter, placebocontrolledstudy of modafinil augmentation in partialresponders to selective serotonin reuptake inhibitors withpersistent fatigue and sleepiness. J Clin Psychiatry 66：85-93, 2005